Jayant Aphale serves as Executive at Sarepta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jayant Aphale has executed 7 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 19, 2016 involved exercising options for 25,000 shares valued at $115.5K.
Jayant Aphale currently holds 36,490 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jayant Aphale has been a net seller of SRPT stock. They have purchased $0 and sold $2.0M worth of shares.
Jayant Aphale's most recent insider trade was on Sep 19, 2016, when they sold 25,000 shares at $4.62 per share.
Get notified when new Form 4 filings are submitted
| $50.00 |
| Discretionary |
| Sep 19, 2016 | SRPT | $500.0K | Sale | 10,000 | $50.00 | Discretionary |
| Sep 19, 2016 | SRPT | $46.2K | Option Exercise | 10,000 | $4.62 | Discretionary |
| Aug 31, 2016 | SRPT | $19.9K | Payment | 765 | $26.07 | Discretionary |
| Feb 29, 2016 | SRPT | $0 | Award | 2,352 | $N/A | Discretionary |
| Nov 12, 2013 | SRPT | $200.1K | Sale | 15,933 | $12.56 | Discretionary |